• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌幸存者的医疗住院情况。

Medical hospitalizations in prostate cancer survivors.

作者信息

Gnanaraj Jerome, Balakrishnan Shobana, Umar Zarish, Antonarakis Emmanuel S, Pavlovich Christian P, Wright Scott M, Khaliq Waseem

机构信息

Department of Medicine, Johns Hopkins Bayview Medical Center, School of Medicine, Johns Hopkins University, 5200 Eastern Avenue, MFL Bldg, West Tower 6th Floor, Baltimore, MD, 21224, USA.

Department of General Surgery, Royal Lancaster Infirmary, Lancaster, UK.

出版信息

Med Oncol. 2016 Jul;33(7):81. doi: 10.1007/s12032-016-0796-y. Epub 2016 Jun 20.

DOI:10.1007/s12032-016-0796-y
PMID:27324503
Abstract

The objectives of the study were to explore the context and reasons for medical hospitalizations among prostate cancer survivors and to study their relationship with obesity and the type of prostate cancer treatment. A retrospective review of medical records was performed at an academic institution for male patients aged 40 years and older who were diagnosed and/or treated for prostate cancer 2 years prior to the study's observation period from January 2008 to December 2010. Unpaired t test, ANOVA, and Chi-square tests were used to compare patients' characteristics, admission types, and medical comorbidities by body mass index (BMI) and prostate cancer treatment. Mean age for the study population was 76 years (SD = 9.2). Two hundred and forty-five prostate cancer survivors were stratified into two groups: non-obese (BMI < 30 kg/m(2)) and obese (BMI ≥ 30 kg/m(2)). The study population's characteristics analyzed by BMI were similar including Gleason score, presence of metastatic disease and genitourinary-related side effects. Only 13 % of admissions were for complaints related to their genitourinary system. Neither the specific treatment that the patients had received for their prostate cancer, nor obesity was associated with the reasons for their medical admission. Survivorship after having a diagnosis of prostate cancer is often lengthy, and these men are at risk of being hospitalized, as they get older. From this inquiry, it has become clear that neither body mass index nor prior therapy is associated with specific admission characteristics, and only a minority of such admissions was directly related to prostate cancer or the genitourinary tract.

摘要

该研究的目的是探讨前列腺癌幸存者住院治疗的背景和原因,并研究其与肥胖及前列腺癌治疗类型的关系。在一所学术机构对年龄40岁及以上的男性患者进行了病历回顾性研究,这些患者在2008年1月至2010年12月研究观察期前2年被诊断和/或接受过前列腺癌治疗。采用非配对t检验、方差分析和卡方检验,按体重指数(BMI)和前列腺癌治疗方式比较患者的特征、入院类型和合并症。研究人群的平均年龄为76岁(标准差=9.2)。245名前列腺癌幸存者被分为两组:非肥胖组(BMI<30kg/m²)和肥胖组(BMI≥30kg/m²)。按BMI分析的研究人群特征相似,包括 Gleason评分、转移性疾病的存在情况和泌尿生殖系统相关副作用。只有13%的入院是因与泌尿生殖系统相关的主诉。患者接受的前列腺癌具体治疗以及肥胖均与入院原因无关。前列腺癌确诊后的生存期通常较长,随着年龄增长,这些男性有住院风险。从这项调查可以清楚地看出,体重指数和既往治疗均与特定的入院特征无关,且此类入院中只有少数与前列腺癌或泌尿生殖道直接相关。

相似文献

1
Medical hospitalizations in prostate cancer survivors.前列腺癌幸存者的医疗住院情况。
Med Oncol. 2016 Jul;33(7):81. doi: 10.1007/s12032-016-0796-y. Epub 2016 Jun 20.
2
Predictors of recurrent hospital admissions among prostate cancer survivors.前列腺癌幸存者再次入院的预测因素。
Med Oncol. 2017 Sep;34(9):150. doi: 10.1007/s12032-017-1013-3. Epub 2017 Jul 27.
3
The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.直肠指检在肥胖患者前列腺癌检测中作为诊断试验的作用。
J BUON. 2015 Nov-Dec;20(6):1601-5.
4
Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.肥胖与前列腺癌初诊时的临床风险因素:来自CaPSURE的数据。
J Urol. 2005 Mar;173(3):732-6. doi: 10.1097/01.ju.0000152408.25738.23.
5
Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea.在韩国的活检人群中,肥胖与前列腺癌检出风险升高相关。
BJU Int. 2014 Dec;114(6):891-5. doi: 10.1111/bju.12600. Epub 2014 Oct 20.
6
Influence of obesity on tumour volume in patients with prostate cancer.肥胖对前列腺癌患者肿瘤体积的影响。
BJU Int. 2012 Mar;109(5):678-84. doi: 10.1111/j.1464-410X.2011.10453.x. Epub 2011 Jul 20.
7
The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance.在适合主动监测的低危前列腺癌患者中,体质量指数增加与疾病升级风险相关。
Eur Urol. 2012 Feb;61(2):356-62. doi: 10.1016/j.eururo.2011.07.041. Epub 2011 Jul 21.
8
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.肥胖与经会阴模板引导前列腺靶向穿刺活检的不良病理发现无关。
Urol Oncol. 2011 Jul-Aug;29(4):398-404. doi: 10.1016/j.urolonc.2009.08.023. Epub 2009 Nov 27.
9
[Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer].[肥胖对临床局限性前列腺癌患者临床病理特征的影响]
Zhonghua Wai Ke Za Zhi. 2013 Dec;51(12):1089-93.
10
Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy.肥胖是否会影响前列腺特异性抗原 (PSA) 在预测接受前列腺活检的男性前列腺癌中的准确性。
BJU Int. 2013 Aug;112(4):E265-71. doi: 10.1111/j.1464-410X.2012.11766.x. Epub 2013 Feb 21.

引用本文的文献

1
Profile of hospitalizations for neoplasms in the Brazilian Unified Health System: a time-series study.巴西统一卫生系统中肿瘤住院患者特征:时间序列研究。
Rev Saude Publica. 2021 Nov 22;55:83. doi: 10.11606/s1518-8787.2021055003192. eCollection 2021.
2
Predictors of recurrent hospital admissions among prostate cancer survivors.前列腺癌幸存者再次入院的预测因素。
Med Oncol. 2017 Sep;34(9):150. doi: 10.1007/s12032-017-1013-3. Epub 2017 Jul 27.

本文引用的文献

1
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
2
Cancer treatment and survivorship statistics, 2014.癌症治疗和生存统计,2014 年。
CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71. doi: 10.3322/caac.21235. Epub 2014 Jun 1.
3
Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.前列腺癌根治性前列腺切除术与放射治疗的比较疗效:死亡率结局的观察性研究
BMJ. 2014 Feb 26;348:g1502. doi: 10.1136/bmj.g1502.
4
Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy.体重指数会影响接受外照射放疗的前列腺癌患者的胃肠道和泌尿生殖系统毒性。
Oncol Lett. 2014 Jan;7(1):209-214. doi: 10.3892/ol.2013.1658. Epub 2013 Nov 5.
5
Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate cancer.接受根治性前列腺切除术治疗局限性前列腺癌的男性患者的长期控尿效果。
Eur Urol. 2014 Jan;65(1):52-7. doi: 10.1016/j.eururo.2013.08.006. Epub 2013 Aug 9.
6
Obesity and prostate cancer: weighing the evidence.肥胖与前列腺癌:权衡证据。
Eur Urol. 2013 May;63(5):800-9. doi: 10.1016/j.eururo.2012.11.013. Epub 2012 Nov 15.
7
Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis.体重指数、前列腺癌特异性死亡率和生化复发:系统评价和荟萃分析。
Cancer Prev Res (Phila). 2011 Apr;4(4):486-501. doi: 10.1158/1940-6207.CAPR-10-0229. Epub 2011 Jan 13.
8
Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.无激素治疗局部前列腺癌患者的主要治疗方法对生活质量的影响。
J Clin Oncol. 2010 Nov 1;28(31):4687-96. doi: 10.1200/JCO.2009.25.3245. Epub 2010 Oct 4.
9
Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.康复后的生存情况:局限性前列腺癌治疗后48个月的生活质量结果
J Natl Cancer Inst. 2009 Jun 16;101(12):888-92. doi: 10.1093/jnci/djp114. Epub 2009 Jun 9.
10
Cause of death in older men after the diagnosis of prostate cancer.
J Am Geriatr Soc. 2009 May;57(5):934-5. doi: 10.1111/j.1532-5415.2009.02241.x.